Publisher Correction: GDF15 mediates the effects of metformin on body weight and energy balance.

Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
Feb 2020
Historique:
pubmed: 14 2 2020
medline: 14 2 2020
entrez: 14 2 2020
Statut: ppublish

Résumé

An Amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41586-020-2031-4 PMID: 32051582
pubmed: 32051582
doi: 10.1038/s41586-020-2031-4
pii: 10.1038/s41586-020-2031-4
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

E24

Subventions

Organisme : British Heart Foundation
ID : RG/12/13/29853
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12015/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12012/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0802051
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00014/5
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 200848/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12012/5
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/18/7/33636
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0600717
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00014/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12012/3
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00014/3
Pays : United Kingdom

Commentaires et corrections

Type : ErratumFor

Auteurs

Anthony P Coll (AP)

MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK. apc36@cam.ac.uk.

Michael Chen (M)

NGM Biopharmaceuticals, South San Francisco, CA, USA.

Pranali Taskar (P)

NGM Biopharmaceuticals, South San Francisco, CA, USA.

Debra Rimmington (D)

MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

Satish Patel (S)

MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

John A Tadross (JA)

MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

Irene Cimino (I)

MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

Ming Yang (M)

MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

Paul Welsh (P)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Samuel Virtue (S)

MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

Deborah A Goldspink (DA)

MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

Emily L Miedzybrodzka (EL)

MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

Adam R Konopka (AR)

Division of Endocrinology, Mayo Clinic, Rochester, MN, USA.

Raul Ruiz Esponda (RR)

Division of Endocrinology, Mayo Clinic, Rochester, MN, USA.

Jeffrey T-J Huang (JT)

Division of Systems Medicine, School of Medicine, University of Dundee, Dundee, UK.

Y C Loraine Tung (YCL)

MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

Sergio Rodriguez-Cuenca (S)

MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

Rute A Tomaz (RA)

Wellcome -Medical Research Council Cambridge Stem Cell Institute, Department of Surgery, University of Cambridge, Cambridge, UK.

Heather P Harding (HP)

Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.

Audrey Melvin (A)

MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

Giles S H Yeo (GSH)

MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

David Preiss (D)

MRC Population Health Research Unit, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Antonio Vidal-Puig (A)

MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

Ludovic Vallier (L)

Wellcome -Medical Research Council Cambridge Stem Cell Institute, Department of Surgery, University of Cambridge, Cambridge, UK.

K Sreekumaran Nair (KS)

Division of Endocrinology, Mayo Clinic, Rochester, MN, USA.

Nicholas J Wareham (NJ)

MRC Epidemiology Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

David Ron (D)

Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.

Fiona M Gribble (FM)

MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

Frank Reimann (F)

MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

Naveed Sattar (N)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

David B Savage (DB)

MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

Bernard B Allan (BB)

NGM Biopharmaceuticals, South San Francisco, CA, USA.

Stephen O'Rahilly (S)

MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK. so104@medschl.cam.ac.uk.

Classifications MeSH